The cancer “clock” in Taiwan “sped up” by 17 seconds in 2022 from the year before, meaning that a new cancer case is diagnosed every four minutes and two seconds in Taiwan, the Health Promotion Administration (HPA) said yesterday.
Prior to 2019, the number of cancer cases increased by 4,000 to 5,000 a year, HPA Cancer Prevention and Control Division Director Lin Li-ju (林莉茹) said.
During the COVID-19 pandemic, people’s willingness to seek medical treatment decreased, but as the pandemic eased in 2022, people started getting screenings and medical treatment again, resulting in an increase in the number of new cancer patients, Lin said.
Photo: Taipei Times
Cancer has been the leading cause of death in the country for 42 years, with more than 50,000 people dying from it every year, HPA data showed.
In 2022, lung cancer was the most common, with 17,982 cases, followed by 17,643 cases of colon or rectal cancer and 17,366 cases of female breast cancer.
Compared with the previous year, the incidence rates for breast, lung, prostate, uterine, stomach, thyroid and skin cancer all increased.
A rise in the number of cancer cases is not necessarily negative. The proportion of early cancer detection for the three most common cancers also increased, meaning there are more opportunities for treatment.
Meanwhile, the National Health Insurance Administration (NHIA) yesterday said that 30 new medical services are now available to patients as part of the National Health Insurance (NHI) scheme, including genetic cancer screenings that can detect seven different strains of cancer. It was introduced on Dec. 1.
The new services are to be awarded 123 million NHI points (one point is about NT$0.9 of funding) to benefit 66,000 patients annually, with an investment of NT$110 million (US$3.37 million), it said.
The NHIA is to award 5 million points to cover the Ozaki procedure for people under 18 who have aortic valve disease.
It is a new surgical procedure to reconstruct the aortic valve and has a high recovery rate, which reduces the need for repeat surgeries, Medical Affairs Division Director Chen Yi-chieh (陳依婕) said, adding that it would benefit about 13 patients per year.
The NHIA is to also offer the prostate-specific antigen isoform test to about 19,000 people per year, Chen said, adding that the test does not need biopsies, is more reliable than the current test and reduces the risk of complications.
Testing for the hepatitis B core related antigen, a biomarker that indicates viral replication of hepatitis B, is also available, he said.
The new test reduces the high relapse rate and complication risk for people who have chronic hepatitis B and stop antiviral treatment, which would help about 34,000 patients per year, he added.
As medical technology is continuously developing, new medical treatments are to continue to be added and revised under the NHI budget, Chen said.
The NHIA is working together with medical experts and insurance plan holders to offer people the latest medical technology, he added.
CHIPMAKING INVESTMENT: J.W. Kuo told legislators that Department of Investment Review approval would be needed were Washington to seek a TSMC board seat Minister of Economic Affairs J.W. Kuo (郭智輝) yesterday said he received information about a possible US government investment in Taiwan Semiconductor Manufacturing Co (TSMC, 台積電) and an assessment of the possible effect on the firm requires further discussion. If the US were to invest in TSMC, the plan would need to be reviewed by the Department of Investment Review, Kuo told reporters ahead of a hearing of the legislature’s Economics Committee. Kuo’s remarks came after US Secretary of Commerce Howard Lutnick on Tuesday said that the US government is looking into the federal government taking equity stakes in computer chip manufacturers that
POWER PLANT POLL: The TPP said the number of ‘yes’ votes showed that the energy policy should be corrected, and the KMT said the result was a win for the people’s voice The government does not rule out advanced nuclear energy generation if it meets the government’s three prerequisites, President William Lai (賴清德) said last night after the number of votes in favor of restarting a nuclear power plant outnumbered the “no” votes in a referendum yesterday. The referendum failed to pass, despite getting more “yes” votes, as the Referendum Act (公民投票法) states that the vote would only pass if the votes in favor account for more than one-fourth of the total number of eligible voters and outnumber the opposing votes. Yesterday’s referendum question was: “Do you agree that the Ma-anshan Nuclear Power Plant
Chinese Nationalist Party (KMT) lawmakers have declared they survived recall votes to remove them from office today, although official results are still pending as the vote counting continues. Although final tallies from the Central Election Commission (CEC) are still pending, preliminary results indicate that the recall campaigns against all seven KMT lawmakers have fallen short. As of 6:10 pm, Taichung Legislators Yen Kuan-heng (顏寬恒) and Yang Chiung-ying (楊瓊瓔), Hsinchu County Legislator Lin Szu-ming (林思銘), Nantou County Legislator Ma Wen-chun (馬文君) and New Taipei City Legislator Lo Ming-tsai (羅明才) had all announced they
Nvidia Corp CEO Jensen Huang (黃仁勳) yesterday visited Taiwan Semiconductor Manufacturing Co (TSMC, 台積電), as the chipmaker prepares for volume production of Nvidia’s next-generation artificial intelligence (AI) chips. It was Huang’s third trip to Taiwan this year, indicating that Nvidia’s supply chain is deeply connected to Taiwan. Its partners also include packager Siliconware Precision Industries Co (矽品精密) and server makers Hon Hai Precision Industry Co (鴻海精密) and Quanta Computer Inc (廣達). “My main purpose is to visit TSMC,” Huang said yesterday. “As you know, we have next-generation architecture called Rubin. Rubin is very advanced. We have now taped out six brand new
RSS